1Albanopoulos-K, Armakolas-A, Konstadoulakis-MM, et al. Prognostic significance of circulating antibodies against carcinomebryonic antigen (anti-CEA) in patients with colon cancer[J]. Am J Gastroenterol.,2000,95(4): 1056- 61.
2Tomeczko-J,Napora-p,Dlubek-D, et al. Adjuvant spleen ultrafiltrate immunotherapy in unresectable advanced non small cell lung cancer [J]. Arzneimittelforschung, 1997, 47(12):1411 - 1416.
3Fujita-T; Hara-A; Yamazaki-Y. The value of acute-phase protein measurements after curative gastric cancer surgery [J]. Arch Surg, 1999,134 (1): 73 - 75.
4Simonetti RG. Hepatocellular carcinoma: a worldwide problem and the major risk factors [J]. Dig Sci, 1991,36 (5):962.
6Lee KK, Kim DG, Moon IS, et al. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma [ J]. J Surg Oncol, 2010,101 (1) :47-53.
7Mazzaferro V,Chun YS, Poon RT, et al. Liver transplantation for hepatocellular careinoma [ J]. Ann Surg Oncol, 2008, 15 (4) :1001-1007.
8Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact smwival [ J ]. Hepatology, 2001,33 ( 6 ) : 1394-1403.
9Charbonneau B,Maurer M J, Fdericksen ZS, et al. Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma [J]. Am J Hematol,2012,87 (9) :880-885.
10Oka R,Sasagawa T, Ninomiya I, et al. Reduction in the local expression of complement component 6 (C6) and 7 ( C7 ) mRNAs in oesophageal carcinoma [J]. Eur J Cancer, 2001 ,37 (9) :1158-1165.
